Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Empagliflozin attenuates pulmonary vascular hemodynamic progression and improves right ventricular adaptation in overcirculation-induced pulmonary hypertension

Right ventricular (RV) failure is the principal determinant of prognosis in pulmonary arterial hypertension (PAH). While current therapies primarily target pulmonary vasoconstriction and vascular remodeling, no treatment directly addresses RV maladaptation. Sodium–glucose cotransporter-2 (SGLT2) inhibitors exert...

C. Real, I. García-Lunar, E. Sandoval et al. · 0 citations
Open access Oct 2026

Deep phenotyping of the right ventricular–pulmonary circulation reveals biological overlap between pulmonary arterial hypertension and combined post-capillary pulmonary hypertension

The distinction between pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with left heart disease (PH-LHD) remains clinically relevant but biologically uncertain, particularly in combined post- and precapillary PH (CpcPH) and PAH associated with cardiovascular comorbidities (coPAH)....

J. J. Rodríguez-Arias, C. Palacios, B. Ayala et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.